Jeevan Scientific Technology (538837.BO) Stock Price

Jeevan Scientific Technology Price

CLOSED
86.00
​
Market closed

Revenue has compounded at 23.1% per year over the past 14 years to 615.37 M INR. Earnings per share have grown at 16.7% per year over the last 14 years. Jeevan Scientific Technology's net margin stands at 1.9%, down from 21.7% several years earlier. Jeevan Scientific Technology currently offers a dividend yield of about 1.40%. The payout ratio is around 14% of earnings. The dividend has grown at 54.9% per year over the past 2 years.

Jeevan Scientific Technology stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Jeevan Scientific Technology business model & stock analysis

Jeevan Scientific Technology Ltd generates revenue by providing global management consulting and technology services through its core segments of clinical research and information technology. The company leverages its expertise in outsourcing to support clients with a comprehensive suite of offerings, including clinical operations, bioanalytical research, and pathology laboratory services. These capabilities are structured to address specific needs within the pharmaceutical and healthcare sectors, ensuring robust support for complex scientific and regulatory requirements. The firm monetizes its clinical research services by delivering specialized solutions such as bioanalytical and bioequivalence studies, clinical trials, and trial management. Additional revenue streams are created through pharmacovigilance services, which encompass risk management plans and signal detection. The company also provides essential support functions like medical writing, clinical trial monitoring, drug safety management, and clinical data management, thereby offering end-to-end solutions for its clients. In the information technology segment, Jeevan Scientific Technology Ltd complements its scientific services with technical expertise in biostatistics, statistical programming, and quality assurance. By integrating these IT services with its clinical research capabilities, the company delivers a unified value proposition to its customer base. This integrated approach allows the firm to capture value across multiple touchpoints in the clinical development lifecycle, from initial study design to final data analysis and safety monitoring.

Frequently asked questions about Jeevan Scientific Technology

Converted at the current exchange rate, the Jeevan Scientific Technology share trades at 0.84 EUR (86.00 INR).

The revenue of Jeevan Scientific Technology is 615.37 M INR. This figure is based on current financial data and reflects the company's business performance.

The profit of Jeevan Scientific Technology is 11.51 M INR. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Jeevan Scientific Technology is currently 148.86. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Jeevan Scientific Technology stock.

The price-to-sales ratio (P/S) of Jeevan Scientific Technology is currently 2.78. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Jeevan Scientific Technology stock.

The Eulerpool Quality Score for Jeevan Scientific Technology is 6/10.

The ISIN of Jeevan Scientific Technology is INE237B01018. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Jeevan Scientific Technology is 538837.BO. The ticker symbol is used to trade Jeevan Scientific Technology shares on the stock exchange.

Fair ValueTerminal
86.00 INR
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Life Sciences Tools & Services
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Currency
INR
Initial public offering
Dec 19, 2014
ISIN
INE237B01018
Cusip
Y4S2CJ106
Market capitalization
1.71 B INRSmall Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
51.09
P/B Ratio
2.39
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
1.41 %
Dividend
Dividend yield
0.00 %
Payout Ratio
14.60 %
Dividend growth Ø5Y
—
Dividend payments per year
1
Dividend paid since
0 years
Dividend not reduced since
0 years
Dividend increased since
0 years
Dividend withholding tax
20.00 %
Last updated Nov 21, 2026, 3:42 AM

Jeevan Scientific Technology Peer Group

Jeevan Scientific Technology FIGI

JVST:IN · BBG007R1QVH7JVST:IB · BBG007R1QVL2